Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 21, 2014; 20(31): 10802-10812
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10802
Published online Aug 21, 2014. doi: 10.3748/wjg.v20.i31.10802
Ref. | No. of patients | Results |
CA 19-9 levels | ||
Park et al[8] | 340 | Elevated CA19-9 levels (> 670 U/mL) were found to independent prognostic factor for OS |
Zhang et al[7] | 302 | mOS, 3.8 mo for patients with high CA 19-9 levels vs 5.0 mo for those with normal CA 19-9 levels |
Humphris et al[47] | 260 | mOS, 25.6 mo for low postoperative CA 19-9 levels vs 14.8 mo for high CA 19-9 levels |
Normalization of CA19-9 within 6 mo of resection was also an independent favorable prognostic factor | ||
Other tumor markers | ||
Zhang et al[7] | 302 | mOS, 2.0 mo for patients with high CEA levels vs 5.0 mo for those with normal CEA levels |
Lee et al[22] | 187 | mOS was 16.3 and 10.2 mo for patients with normal CEA vs high CEA levels, repsectively |
Hematological factors | ||
Zhang et al[7] | 302 | WBCs were independent prognostic factor for OS |
Smith et al[58] | 110 | mOS in patients with a preoperative PLR of 150 or less was 19.7 mo, 13.7 mo in those with a PLR of 151-300, and 5.8 mo in patients with a value of > 300 |
Aliustaoglu et al[57] | 65 | Patients with a NLR value of < 5 had a significantly higher median OS time compared to those with a NLR value of ≥ 5 |
Stotz et al[56] | 371 | An increased NLR as an independent prognostic factor for inoperable and surgically resected patients |
Biochemical parameters | ||
Zhang et al[7] | 302 | Serum albumin and BUN levels were found to be independent prognostic factors for prediction of OS |
Stocken et al[46] | 653 | Albumin, ALP, LDH, BUN, and AST were independent prognostic indicators for survival of advanced pancreatic cancer |
Haas et al[60] | 291 | Pretreatment LDH levels were significantly associated with TTP. Baseline LDH,CRP, and bilirubin were significant prognostic factors for OS |
- Citation: Bilici A. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol 2014; 20(31): 10802-10812
- URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10802.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i31.10802